![]() | - SMTL ID
- 8x7h.1
- Ligands
- ~{N}-[4-[6-[3-[4-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoyl]piperazin-1-yl]propoxy]-1~{H}-benzimidazol-2-yl]cyclohexyl]-2-(1~{H}-indol-2-ylmethylamino)ethanamide; GLYCEROL
- Polypeptides
- Glucose-induced degradation protein 4 homolog; Bromodomain-containing protein 4
- Oligo-state
- hetero-1-1-mer
|
![]() | - SMTL ID
- 8x7h.2
- Ligands
- ~{N}-[4-[6-[3-[4-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoyl]piperazin-1-yl]propoxy]-1~{H}-benzimidazol-2-yl]cyclohexyl]-2-(1~{H}-indol-2-ylmethylamino)ethanamide; GLYCEROL
- Polypeptides
- Glucose-induced degradation protein 4 homolog; Bromodomain-containing protein 4
- Oligo-state
- hetero-1-1-mer
|
![]() | - SMTL ID
- 8x7h.3
- Ligands
- ~{N}-[4-[6-[3-[4-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoyl]piperazin-1-yl]propoxy]-1~{H}-benzimidazol-2-yl]cyclohexyl]-2-(1~{H}-indol-2-ylmethylamino)ethanamide
- Polypeptides
- Glucose-induced degradation protein 4 homolog; Bromodomain-containing protein 4
- Oligo-state
- hetero-1-1-mer
|
![]() | - SMTL ID
- 8x7h.4
- Ligands
- ~{N}-[4-[6-[3-[4-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoyl]piperazin-1-yl]propoxy]-1~{H}-benzimidazol-2-yl]cyclohexyl]-2-(1~{H}-indol-2-ylmethylamino)ethanamide; GLYCEROL
- Polypeptides
- Glucose-induced degradation protein 4 homolog; Bromodomain-containing protein 4
- Oligo-state
- hetero-1-1-mer
|